ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,991Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 337

$534K Total Retail Price of All Prescriptions

Rank: 59 out of 337

592 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 592 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 592 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 13,646 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 977 864 1 1
AMLODIPINE BESYLATE 892 849 2 3
ATENOLOL 756 684 3 10
LEVOTHYROXINE SODIUM 638 571 4 5
HYDROCHLOROTHIAZIDE 550 544 5 9
METOPROLOL TARTRATE 505 502 6 6
LISINOPRIL 497 410 7 2
OMEPRAZOLE 478 424 8 4
ALENDRONATE SODIUM 419 397 9 19
ATORVASTATIN CALCIUM 403 389 10 7
FUROSEMIDE 360 337 11 8
SERTRALINE HCL 347 314 12 18
ENALAPRIL MALEATE 292 273 13 37
RANITIDINE HCL 243 235 14 30
LOVASTATIN 243 243 14 24
METFORMIN HCL 217 201 16 12
DIOVAN 179 178 17 26
TRAZODONE HCL 166 149 18 16
GABAPENTIN 164 137 19 20
HYDROCODONE-ACETAMINOPHEN 164 100 S3 19 13
TAMSULOSIN HCL 162 156 21 25
DONEPEZIL HCL 160 152 22 22
ALLOPURINOL 157 145 23 28
PRAVASTATIN SODIUM 153 142 24 14
METOPROLOL SUCCINATE 122 111 25 21
CITALOPRAM HBR 120 102 26 17
LOSARTAN POTASSIUM 120 113 26 15
LIPITOR 119 116 28 33
QUINAPRIL HCL 114 114 29 50
TRIAMTERENE-HCTZ 110 103 30 39
WARFARIN SODIUM 110 110 30 11
BENAZEPRIL HCL 106 106 32 109
GLYBURIDE 105 80 R 33 53
TRAMADOL HCL 101 87 34 32
GLIPIZIDE ER 99 99 35 69
GLIPIZIDE 95 95 36 45
PROPRANOLOL HCL 95 91 36 121
SPIRIVA 95 70 36 43
MIRTAZAPINE 92 92 39 27
PROAIR HFA 89 84 40 38
ALPRAZOLAM 86 74 41 78
SYNTHROID 86 86 41 41
POLYETHYLENE GLYCOL 3350 86 85 41 47
CLOPIDOGREL 84 84 44 42
IBUPROFEN 79 66 45 64
AZITHROMYCIN 78 68 46 51
COMBIVENT 77 77 47 126
GLYBURIDE-METFORMIN HCL 76 42 R 48 99
PLAVIX 76 76 48 74
GLIPIZIDE XL 75 75 50 123
DIGOXIN 75 75 50 58
PANTOPRAZOLE SODIUM 72 64 52 36
FELODIPINE ER 71 59 53 79
NIFEDIPINE ER 68 68 54 111
FINASTERIDE 67 67 55 83
ISOSORBIDE MONONITRATE ER 66 66 56 70
PAROXETINE HCL 65 65 57 46
VERAPAMIL ER 61 58 58 77
NAMENDA 57 57 59 35
AMITRIPTYLINE HCL 57 53 R 59 75
AMLODIPINE BESYLATE-BENAZEPRIL 57 40 59 97
MELOXICAM 55 49 62 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 14, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.